Socrates E. Papapoulos
Impact in
- Orthopedics and Sports Medicine top 0.02%
- Bone health and osteoporosis research
- Bone and Joint Diseases
- Oncology top 0.1%
- Bone health and treatments
Papers in
-
- Bone health and osteoporosis research 141
- Bone and Joint Diseases 59
- Oncology 201
- Bone health and treatments 194
- Cancer Diagnosis and Treatment 17
- Co-authors
- Clemens W.G.M. LöwikNeveen A. T. HamdyRutger L. van BezooijenGabri van der PluijmNatasha M. Appelman‐DijkstraHerman A. HamersmaErmond van BeekMarcel Karperien
- Journals
- Journal of Bone and Mineral Research (38 papers)Bone (38 papers)Osteoporosis International (25 papers)The Journal of Clinical Endocrinology & Metabolism (18 papers)Calcified Tissue International (8 papers)
- Partner nations
- NetherlandsUnited StatesSwitzerland
In The Last Decade
Socrates E. Papapoulos
298 papers receiving 16.9k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Orthopedics and Sports Medicine 7.3k
- Oncology 9.2k
- Nephrology 1.2k
- Rheumatology 1.9k
- Molecular Biology 7.3k
Countries citing papers authored by Socrates E. Papapoulos
This map shows the geographic impact of Socrates E. Papapoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Socrates E. Papapoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Socrates E. Papapoulos more than expected).
Fields of papers citing papers by Socrates E. Papapoulos
This network shows the impact of papers produced by Socrates E. Papapoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Socrates E. Papapoulos. The network helps show where Socrates E. Papapoulos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Socrates E. Papapoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 43 | |
| 4 | 2020 | 10 | |
| 5 | 2018 | 129 | |
| 6 | TEN YEARS OF DENOSUMAB (DMAB) TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FREEDOM EXTENSION TRIAL | 2016 | 1 |
| 7 | Denosumab treatment in postmenopausal women with osteoporosis for up to 9 years: results through year 6 of the freedom extension | 2015 | 2 |
| 8 | Evolution of subject characteristics in FREEDOM and its extension for up to 8 years | 2015 | 2 |
| 9 | EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST FIVE YEARS OF THE FREEDOM EXTENSION | 2014 | 12 |
| 10 | Relationship Between Changes in Bone Mineral Density and Incidence of Fracture with 6 Years of Denosumab Treatment | 2012 | 1 |
| 11 | Treatment of postmenopausal women with osteoporosis for six years with denosumab : three-year results from the freedom extension | 2012 | 1 |
| 12 | DENOSUMAB TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR 6 YEARS: RESULTS FROM THE FIRST 3 YEARS OF THE FREEDOM EXTENSION | 2012 | 2 |
| 13 | Safety observations from denosumab long-term extension and cross-over studies in postmenopausal women with osteoporosis | 2011 | 3 |
| 14 | FIVE-YEAR DENOSUMAB TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION | 2011 | 9 |
| 15 | Long-term denosumab treatment of postmenopausal women with osteoporosis: results from the first year extension study of the FREEDOM trial | 2010 | 2 |
| 16 | 2007 | 157 | |
| 17 | 1999 | 40 | |
| 18 | 1997 | 18 | |
| 19 | Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. | 1995 | 91 |
| 20 | 1994 | 197 |
About Socrates E. Papapoulos
Socrates E. Papapoulos is a scholar working on Orthopedics and Sports Medicine, Oncology, Nephrology, Molecular Biology and Rheumatology, having authored 303 papers that have together received 17.5k indexed citations. Recurring topics across this work include Bone health and treatments (194 papers), Bone health and osteoporosis research (141 papers), Bone Metabolism and Diseases (77 papers), Bone and Joint Diseases (59 papers), Parathyroid Disorders and Treatments (33 papers), Medical Imaging and Pathology Studies (20 papers), Cancer Diagnosis and Treatment (17 papers) and Vitamin D Research Studies (16 papers). The work is most often cited by research in Orthopedics and Sports Medicine (7.3k citations), Oncology (9.2k citations), Nephrology (1.2k citations), Rheumatology (1.9k citations) and Molecular Biology (7.3k citations). Socrates E. Papapoulos has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Clemens W.G.M. Löwik, Neveen A. T. Hamdy, Rutger L. van Bezooijen, Gabri van der Pluijm, Natasha M. Appelman‐Dijkstra, Herman A. Hamersma, Ermond van Beek, Marcel Karperien, O. L. M. Bijvoet and Martine Deckers. Their work appears in journals such as Journal of Bone and Mineral Research, Bone, Osteoporosis International, The Journal of Clinical Endocrinology & Metabolism and Calcified Tissue International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.